United States · Investor

AbbVie

Last cheque observed Jun 2026; 53 cheques on record.

Deploying nowCorporate VC

GrowthSeedSeries ABioTechBiotechnologyComputer

Deploying now
36%of best year4cheques in 12 months, 53 on record
Since the last cheque147days00hrs00min00sec
Median round$45MRounds led0 of 53Sole investor5 roundsMostly inUnited States, 81%
Pitch AbbVie

AbbVie highlights

  1. 01

    4 cheques in the last 12 months

  2. 02

    Mostly Series A and Venture: 67% of its rounds

  3. 03

    Sole investor in 5 rounds, median $9.7M

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Stages
GrowthSeedSeries ASeries B
Sectors
BioTechBiotechnologyComputer
Based in
North Chicago, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first53 appearances

  1. 2026

    2 rounds

  2. Jun
    Inventiva PharmaFR$120MWith 4 others
  3. Apr
    Endlyz TherapeuticsSeed · US$17MWith 1 other
  4. 2025

    11 rounds

  5. Dec
    DISCO PharmaceuticalsSeed · DE$42MWith 1 other
  6. Nov
    Artios PharmaSeries D · GB$115MWith 5 others
  7. Oct
    Zag BioSeries A · US · Firms' own news pages$80MWith 9 others
  8. Aug
    Oisin BiotechnologiesSeries A · US$10MSole investor
  9. May
    Syndeio BiosciencesVenture · US$90MWith 2 others
  10. Apr
    ThirtyFiveBioVenture · GBUndisclosedWith 2 others
  11. Apr
    Starday FoodsSeries A · US$8.0MWith 4 others
  12. Feb
    AmbAgon TherapeuticsVenture · US$5.0MWith 2 others
  13. Jan
    Soufflé TherapeuticsSeries A · US$200MWith 4 others
  14. Jan
    Light Horse TherapeuticsSeries A · US$62MWith 2 others
  15. Jan
    CephagenixSeed · DK$9.3MSole investor
  16. 2024

    3 rounds

  17. Nov
    AlectorDebt · US$50MWith 5 others
  18. Jan
    Effector TherapeuticsUS$15MWith 2 others
  19. Jan
    Accent TherapeuticsSeries C · US$75MWith 2 others
  20. 2023

    5 rounds

  21. Jul
    Caribou BiosciencesUS$125MWith 4 others
  22. Jun
    Mozart TherapeuticsSeries A · US$25MWith 4 others
  23. May
    Morphic TherapeuticUS$276MWith 5 others
  24. May
    Quanta TherapeuticsSeries D · US$51MWith 1 other
  25. Feb
    Capsida BiotherapeuticsVenture · USUndisclosedWith 1 other
  26. 2022

    3 rounds

  27. Dec
    Ribon TherapeuticsVenture · US$25MWith 1 other
  28. Nov
    Jnana TherapeuticsSeries C · US$107MWith 4 others
  29. Sept
    Carisma TherapeuticsSeries C · US$30MWith 3 others
  30. 2021

    2 rounds

  31. Nov
    Nitrase TherapeuticsSeries A · US$7.0MWith 2 others
  32. Jul
    Stemson TherapeuticsSeries A · US$15MWith 1 other
  33. 2020

    6 rounds

  34. Dec
    Faze MedicinesSeries A$81MWith 4 others
  35. Nov
    Caraway TherapeuticsVentureUndisclosedWith 3 others
  36. Sept
    Palleon PharmaceuticalsSeries B$100MWith 2 others
  37. Jul
    Magnolia NeuroSciencesVenture$18MWith 3 others
  38. Jan
    PACT PharmaSeries C$75MWith 3 others
  39. Jan
    Quench BioSeries A$50MWith 2 others
  40. 2019

    2 rounds

  41. Aug
    Carisma TherapeuticsSeries A · US · Technical$60MWith 1 other
  42. Mar
    Prevail TherapeuticsSeries B · US · Medcitynews$50MWith 10 others
  43. 2018

    8 rounds

  44. Dec
    Quentis TherapeuticsGrant$1.0MWith 4 others
  45. Nov
    RibometrixSeries A · US · FinSMEs$30MWith 10 others
  46. Nov
    Rodeo TherapeuticsVenture$8.9MWith 3 others
  47. Aug
    ApoGenSeries A · US · FinSMEs$4.0MWith 3 others
  48. Aug
    Magnolia NeuroscienceSeries A · US · FinSMEs$31MWith 10 others
  49. Aug
    ArtiosSeries B · GB · FinSMEs$83MWith 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 13 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Companies it bought

Acquisitions by the firm itself

Pharmacyclics$21BMar 2015
Shire$55BJul 2014

Who they invest alongside

The investors most often in the same rounds as AbbVie. A count of rooms they were both in, not a relationship either has claimed.

Eli LillyCorporate VC7rounds togetherPolaris PartnersVC firm7rounds togetherAlexandria Venture InvestmentsVC firm6rounds togetherARCH Venture PartnersVC firm5rounds togetherRA Capital ManagementPrivate equity5rounds togetherSofinnova PartnersVC firm5rounds togetherVersant VenturesVC firm5rounds togetherAlexandria Real Estate EquitiesVC firm4rounds togetherSR OneCorporate VC4rounds togetherGoogle VenturesCorporate VC3rounds togetherMission BioCapitalVC firm3rounds togetherPfizerCorporate VC3rounds together

Recently backed

The latest companies AbbVie put money into.

Inventiva Pharma$120M · Jun 2026Artios Pharma$115M · Nov 2025Zag Bio$80M · Oct 2025Oisin Biotechnologies$10M · Aug 2025Syndeio Biosciences$90M · May 2025ThirtyFiveBioApr 2025

Quick answers about AbbVie

What does AbbVie invest in?

AbbVie invests most often at Series A and Venture (67% of the rounds on record), in sectors such as BioTech, Biotechnology and Computer.

How active is AbbVie?

53 investments on record, 4 of them in the last 12 months. The most recent was in Jun 2026.

What has AbbVie invested in recently?

Its most recent investments on record: Inventiva Pharma (Undisclosed round, Jun 2026), Endlyz Therapeutics (Seed, Apr 2026) and DISCO Pharmaceuticals (Seed, Dec 2025).

How big are AbbVie's cheques?

The median round it joins is $45M.

Does AbbVie lead rounds?

Rarely, if at all: none of its 53 investments on record names it as the lead.

Where does AbbVie invest?

Most of the companies it backs are in the United States (81%) and the United Kingdom (9%).

Is AbbVie investing now?

Yes: it is actively investing, with 4 investments in the last 12 months.

Who does AbbVie invest alongside?

Most often Eli Lilly (7 rounds together), Polaris Partners (7 rounds together) and Alexandria Venture Investments (6 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it